Medical Oncologist
CION Cancer Clinics
Is Y-90 worth the extra cost compared with TACE? | CION Cancer Clinics
Often not: when TACE suits the tumour and the liver, it is a reasonable first choice and costs less. Y-90 is worth its higher price in particular situations, such as a tumour in the portal vein, a large tumour or when fewer hospital visits matter a lot. This page explains when the extra cost makes sense, how to compare the whole bill and who neither treatment suits. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is Y-90 worth paying more for than TACE?
- When does Y-90 make more sense than TACE?
- How does the total cost of TACE compare with Y-90?
- TACE or Y-90: what is actually different?
- Does paying more mean a better result?
- When is neither TACE nor Y-90 the right spend?
- What this page cannot tell you
- Common questions about choosing Y-90 or TACE
The short answer
Is Y-90 worth paying more for than TACE?
For many people, no: when TACE suits the tumour and the liver, it is a reasonable first choice and costs less. Y-90 earns its higher price in particular situations, such as a tumour that has grown into the portal vein, a large tumour, or when fewer hospital visits matter a lot. Whether it is worth it for you depends on which group you are in.
The two treatments, in one line each
TACE (chemoembolisation) puts chemotherapy and blocking particles into the artery feeding the tumour. Y-90 (TARE, or radioembolisation) puts tiny radioactive beads into the same artery. Both are done by interventional radiologists through a thin tube in the groin or wrist. TACE vs TARE covers how the choice is made in detail.
What the evidence says, honestly
Studies comparing the two directly are fewer than people expect, and they have not settled that one is better for everyone. What they do show is that the two have different strengths. That is why the decision is made tumour by tumour, not by price.
This page is mainly about cancer that started in the liver (HCC). If the cancer spread to the liver from the bowel or elsewhere, read Y-90 for liver metastases.What the team weighs
When does Y-90 make more sense than TACE?
These are the situations where the extra cost is most often judged worthwhile. None of them is automatic.
Tumour in the portal vein
When cancer has grown into the portal vein (the main vein carrying blood into the liver), TACE is often not safe, because blocking the artery too can starve healthy liver. Y-90 blocks far less, so it is sometimes still possible.
A large or single bulky tumour
A large tumour may need several rounds of TACE. Y-90 can sometimes treat it in fewer sittings, which narrows the cost gap.
A bridge to surgery or transplant
Y-90 is sometimes used to hold a tumour in check, or shrink it, while someone waits for surgery or a transplant. Read Y-90 as a bridge.
Fewer trips and a gentler few days
Matters most for
- Families travelling from the districts
- People who struggled after an earlier TACE
- Carers who cannot take repeated leave from work
Indicative cost
How does the total cost of TACE compare with Y-90?
Compare the whole plan, not one session. These are 2026 Hyderabad estimates CION already publishes; Y-90 is quoted separately.
₹75,000 – ₹2,50,000
TACE, per session
Often repeated. Multiply by the number of sessions your team expects to get a fair comparison.
Quoted separately
Y-90, the whole treatment
Includes a mapping procedure and the beads. Usually costs more than one TACE session.
₹3,00,000 – ₹12,00,000 or more
Full multi-step treatment
Many people have more than one treatment over time, whichever they start with.
Indicative only, 2026 Hyderabad estimates, not a quote. Your own figure depends on the hospital, the plan and your insurance or government scheme. Scheme rules change, so check cover at the time of treatment. Call the helpline for help comparing two estimates.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
TACE or Y-90: what is actually different?
TACE
Y-90
Lower cost for each session
Higher cost, mostly the beads
Often repeated several times
Often fewer sittings, after one mapping procedure
Fever, pain and nausea for a few days are common
Tiredness is common; the first few days are often milder
Usually avoided with tumour in the portal vein
Sometimes possible with tumour in the portal vein
Widely available in Hyderabad
Offered at fewer hospitals; depends on bead supply
Commonly believed
Does paying more mean a better result?
"The newer, costlier treatment is always the stronger one."
Y-90 is different, not simply stronger. For a tumour that suits TACE, choosing Y-90 may cost more without changing what happens. The tumour and the liver decide, not the price.
"If we choose the cheaper option, we are letting our father down."
Choosing the treatment the team recommends is the caring choice. Families often feel guilt over money. A plan you can afford to finish is worth more than one you cannot.
"Y-90 avoids side effects altogether."
It has its own risks, including damage to healthy liver and, rarely, beads reaching the stomach or lungs. Read the side effects of Y-90 before deciding.
"Once you start TACE, you can never have Y-90."
Many people move from one to the other, or to tablets or immunotherapy, as the cancer and the liver change. The first choice does not lock you in.
Who this does not suit
When is neither TACE nor Y-90 the right spend?
Some people should not have either treatment, and paying more does not change that. Both depend on a liver that still works reasonably well. When the liver is failing, with deep jaundice or fluid in the belly that keeps returning, either treatment can make things worse.
When the cancer has spread beyond the liver
Both treatments act only inside the liver. If the cancer has spread to the lungs, bones or lymph nodes, systemic treatment such as immunotherapy or targeted tablets usually comes first. Sometimes a liver treatment is added later.
When a small tumour could be removed or ablated
A small tumour in a liver that can cope may be suitable for surgery or ablation, which aim at curative treatment. In that case, spending on either TACE or Y-90 instead may be the wrong decision.
When mapping rules Y-90 out
If the mapping scan shows too many beads would reach the lungs or gut, Y-90 cannot be done safely. TACE or another option is then discussed.
Being straight with you
What this page cannot tell you
It cannot tell you which treatment is right for your tumour, or how either will work for you. That needs a multidisciplinary team looking at your scans, your blood tests and how you are managing day to day. It also cannot give you a price for Y-90; only the treating hospital can.
CION's tumour board reviews the scans and the liver function, explains which option fits and why, and coordinates TACE or Y-90 through accredited partner hospitals. We can also help you compare estimates and prepare insurance or scheme paperwork.
Questions we are asked
Common questions about choosing Y-90 or TACE
Does Y-90 help people live longer than TACE?
The studies so far have not shown that one is clearly better for everyone. They suit different tumours and different livers. Your team cannot promise a result from either. What they can tell you is which one fits your situation, and why they chose it.
Can I ask for Y-90 even if the team suggests TACE?
You can ask, and you should get a clear reason either way. Sometimes Y-90 is a reasonable alternative and the choice comes down to cost and travel. Sometimes it is not suitable. A second opinion is always fair if you are unsure.
How many TACE sessions make it cost as much as Y-90?
It depends on the two quotes you hold. Ask your team how many TACE sessions they expect, then compare that total with the full Y-90 estimate, including mapping. See how many TACE sessions you may need.
Is Y-90 easier on an older or frail person?
The days after Y-90 are often milder than after TACE, and fewer sittings may be needed. But age alone does not decide it. Liver function and general strength matter more. Your team will weigh both before suggesting either.
Will insurance pay for Y-90 if TACE was also an option?
Some insurers ask why the costlier option was chosen. A clear note from the treating team explaining the reason helps. Ask your insurer before treatment. See insurance for TACE and Y-90.
Can Y-90 be combined with immunotherapy?
Combining liver-directed treatment with immunotherapy is being studied, and some teams use it in selected people. The evidence is still developing. Read immunotherapy combined with TACE or Y-90 for what is known.
What if we cannot afford Y-90 at all?
Tell the team plainly. If TACE or another option is reasonable for this tumour, they can plan around it. Check scheme and insurance cover too. CION's team can help with the paperwork and explain what each option means for your family.
Who decides between TACE and Y-90?
A multidisciplinary team, usually including an oncologist, an interventional radiologist and a liver specialist, looking at the same scans together. You and your family should be part of the final decision, including the cost. Call the helpline to arrange a review.
What moves the figure
What affects the cost
Four things change the total more than anything else.
The technique used
A shaped or image-guided delivery costs more than a conventional one, and is chosen on clinical grounds rather than preference.
How many sessions
The total is driven by the number of sittings or cycles, not by a single per-visit figure.
Supporting tests
Scans, blood work and pathology done alongside treatment are billed separately.
Your cover
Aarogyasri, CGHS, ECHS, EHS or cashless insurance usually change the out-of-pocket figure substantially.
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. One helpline books a consultation at any of these centres, and your team will tell you where each test and operation takes place.
Warangal
Vizag
Sources
- RadiologyInfo.org (RSNA/ACR) — Radioembolization (Y90)
- RadiologyInfo.org (RSNA/ACR) — TACE Cancerous Tumor Therapy
- American Cancer Society — Embolization Therapy for Liver Cancer
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Torn between TACE and Y-90?
Send us the scans and both estimates. Our team can explain which option fits this tumour and this liver, and why. One helpline serves every CION centre.